» Articles » PMID: 19556314

The Development and Validation of the Unidimensional Fatigue Impact Scale (U-FIS)

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2009 Jun 27
PMID 19556314
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The multidimensional assessment of fatigue is complicated by the interrelation of its multiple causes and effects.

Objective: The purpose of the research was to develop a unidimensional assessment of fatigue (U-FIS).

Methods: Data collected with the Fatigue Impact Scale (FIS) were subjected to Rasch analysis to identify potential problems with the scale. Additional items for the U-FIS were generated from interviews with UK MS patients. The U-FIS was tested for face and content validity in patient interviews and included in a validation survey to determine dimensionality (Rasch model), reliability and validity.

Results: The original FIS was not unidimensional when subscale items were combined. The modification of the FIS and addition of a number of items allowed the development of a 22-item unidimensional scale (U-FIS) that was reliable (Cronbach Alpha = 0.96; test-retest = 0.86,) and valid given correlations with the Nottingham Health Profile and ability to distinguish between MS severity groups. There was no significant difference in U-FIS scores according to MS type.

Conclusion: It is valid to conceptualize the functional impact of fatigue as unidimensional. The U-FIS is a reliable and valid questionnaire that will allow the measurement of this construct in clinical studies.

Citing Articles

Measuring Fatigue in Multiple Sclerosis: There may be Trouble Ahead.

Close J, Vandercappellen J, King M, Hobart J Neurol Ther. 2023; 12(5):1649-1668.

PMID: 37353721 PMC: 10444927. DOI: 10.1007/s40120-023-00501-9.


Comparison of the Psychometric Properties of Three Fatigue Scales in Persian-Speaking Patients with Multiple Sclerosis.

Behrangrad S, Yoosefinejad A Int J MS Care. 2021; 23(1):8-15.

PMID: 33658900 PMC: 7906033. DOI: 10.7224/1537-2073.2019-051.


Fatigue Profiles in Patients with Multiple Sclerosis are Based on Severity of Fatigue and not on Dimensions of Fatigue.

Beckerman H, Eijssen I, van Meeteren J, Verhulsdonck M, de Groot V Sci Rep. 2020; 10(1):4167.

PMID: 32139797 PMC: 7058058. DOI: 10.1038/s41598-020-61076-1.


Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives.

Ozel O, Vaughn C, Eckert S, Jakimovski D, Lizarraga A, Weinstock-Guttman B Patient Relat Outcome Meas. 2019; 10:373-384.

PMID: 31849554 PMC: 6911812. DOI: 10.2147/PROM.S168095.


Cross-cultural adaptation, validity, and reliability of the Persian version of the spine functional index.

Mokhtarinia H, Hosseini A, Maleki-Ghahfarokhi A, Gabel C, Zohrabi M Health Qual Life Outcomes. 2018; 16(1):95.

PMID: 29764442 PMC: 5952597. DOI: 10.1186/s12955-018-0928-5.